Notable Labs, Ltd.
NTBL · NASDAQ
6/30/2024 | 3/31/2024 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.00 | 0.08 | 0.05 |
| FCF Yield | -66.65% | -23.40% | -12.88% | -12.95% |
| EV / EBITDA | -0.62 | -2.38 | 19.06 | 2.46 |
| Quality | ||||
| ROIC | -56.16% | -28.18% | -1.69% | -16.20% |
| Gross Margin | -3,100.00% | 100.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.71 | 0.95 | 2.63 | 0.64 |
| Growth | ||||
| Revenue 3-Year CAGR | -82.74% | -86.28% | 36.77% | 816,730.92% |
| Free Cash Flow Growth | -4.26% | 0.00% | -37.29% | 73.13% |
| Safety | ||||
| Net Debt / EBITDA | 0.43 | 1.66 | 74.20 | 4.85 |
| Interest Coverage | 0.00 | 0.00 | -29.73 | -173.53 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 6,645.94 | 16,470.00 | 0.00 | -49,500.00 |